Evidence map›Paper›PMID 34315884›Full record

ArticleNature communications2021

Chloride sensing by WNK1 regulates NLRP3 inflammasome activation and pyroptosis.

Lindsey Mayes-Hopfinger, Aura Enache, Jian Xie, Chou-Long Huang, Robert Köchl, Victor L J Tybulewicz, Teresa Fernandes-Alnemri, Emad S Alnemri

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Molecular mechanisms of NLRP3 inflammasome activation.Experimental & molecular medicine · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Transcriptional Repression of CCL2 by KInternational journal of molecular sciences · 2025
    Article
  11. Bilirubin Targeting WNK1 to Alleviate NLRP3-Mediated Neuroinflammation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. NLRP3 inflammasome in health and disease (Review).International journal of molecular medicine · 2025
    Review
  17. The human-specific noncoding RNAFASEB bioAdvances · 2025
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Lindsey Mayes-HopfingerDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, USA.ORCID 0000-0003-0646-479X
Aura EnacheDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, USA.
Jian XieDepartment of Medicine, Division of Nephrology, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
Chou-Long HuangDepartment of Medicine, Division of Nephrology, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
Robert KöchlThe Francis Crick Institute, London, UK.
Victor L J TybulewiczThe Francis Crick Institute, London, UK.ORCID 0000-0003-2439-0798
Teresa Fernandes-AlnemriDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, USA.
Emad S AlnemriDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, USA. emad.alnemri@jefferson.edu.ORCID 0000-0002-7295-3383
Thomas Jefferson University · USUniversity of Iowa · USKing's College London · GBThe Francis Crick Institute · GB

Funding

Cysteine Proteases in ApoptosisR01AR055398 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI ALNEMRI, EMAD S · 2008 to 2018
$4.2M
WNK kinase cascade in health and diseaseR01DK111542 · NIDDK · UNIVERSITY OF IOWA · PI Chou-Long Huang · 2017 to 2026
$3.6M
Regulation of the Cell Death Program by DFNA5R01AR074564 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI ALNEMRI, EMAD S · 2019 to 2023
$2.7M
Caspase-1 Activation by the InflammasomesR01AR078440 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI ALNEMRI, EMAD S · 2021 to 2025
$2.7M
Cancer Research UK FC001194Medical Research CouncilNIAMS NIH HHS R01 AR055398NIAMS NIH HHS R01 AR074564NIAMS NIH HHS R01 AR078440NIDDK NIH HHS R01 DK111542Wellcome TrustWellcome Trust FC001194
6 · The paper itself

Abstract

The NLRP3 inflammasome mediates the production of proinflammatory cytokines and initiates inflammatory cell death. Although NLRP3 is essential for innate immunity, aberrant NLRP3 inflammasome activation contributes to a wide variety of inflammatory diseases. Understanding the pathways that control NLRP3 activation will help develop strategies to treat these diseases. Here we identify WNK1 as a negative regulator of the NLRP3 inflammasome. Macrophages deficient in WNK1 protein or kinase activity have increased NLRP3 activation and pyroptosis compared with control macrophages. Mice with conditional knockout of WNK1 in macrophages have increased IL-1β production in response to NLRP3 stimulation compared with control mice. Mechanistically, WNK1 tempers NLRP3 activation by balancing intracellular Cl

Indexed as

PyroptosisAnimalsCaspase 1ChloridesFemaleImidazolesImmunity, InnateInflammasomesInterleukin-1betaLipopolysaccharidesL-Lactate DehydrogenaseMacrophagesMaleMiceMice, Inbred C57BLModels, BiologicalCaspase 1ChloridesImidazolesInflammasomesInterleukin-1betaLipopolysaccharidesL-Lactate DehydrogenaseNLR Family, Pyrin Domain-Containing 3 ProteinOXSR1 protein, mousePotassiumProtein Serine-Threonine KinasesPyrrolidinesStk39 protein, mouseTamoxifenWnk1 protein, mouseWNK463WNK Lysine-Deficient Protein Kinase 1

Identifiers

PMID34315884
PMCPMC8316491
OpenAlexW3184303391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.